Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Immune Responses to Different Influenza Vaccines in Healthy Adults
NCT03068949Phase 4Completed
- Sponsor
- University of Rochester
- Start
- Oct 2015
- Primary completion
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine, Fluzone Trivalent, influenza vaccine (quadrivalent, high-dose) in influenza, sponsored by University of Rochester. Started Oct 2015; status: completed.
02
Drugs
influenza vaccineFluzone Trivalentinfluenza vaccine (quadrivalent, high-dose)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03068949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03068949.